Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Olanow

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Neurology|October 1, 1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseJ M Cedarbaum, C W Olanow
Neurosurgery|January 1, 1981
Phenytoin: pharmacokinetics and clinical therapeuticsC W Olanow, A L Finn
The Surgical Clinics of North America|August 1, 1980
Myasthenia gravisA S Wechsler, C W Olanow
Annals of Neurology|April 29, 2009
Withdrawal of figure 2 from McNaught and Olanow's article, "Proteasome inhibitor-induced model of Parkinson's disease" (Ann Neurol 2006;60:243-247)K S McNaught, C W Olanow
Archives of Neurology|October 1, 1991
Early therapy for Parkinson's diseaseR A Hauser, C W Olanow
Biochimica Et Biophysica Acta|March 17, 1999
Apoptosis in neurodegenerative diseases: the role of mitochondriaW G Tatton, C W Olanow
Annals of Neurology|April 13, 2000
Preventing levodopa-induced dyskinesiasC W Olanow, J A Obeso
Neurology|January 9, 2001
Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitorsC W Olanow, J A Obeso
Advances in Neurology|September 14, 2001
Surgical therapies for Parkinson's disease. A physician's perspectiveC W Olanow, M F Brin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1981
Brain stem glioma in childhood: acute hemiplegic onsetS J Rothman, C W Olanow
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Neurology|October 1, 1991
Dopamine sulfate in ventricular cerebrospinal fluid and motor function in Parkinson's diseaseJ M Cedarbaum, C W Olanow
Neurosurgery|January 1, 1981
Phenytoin: pharmacokinetics and clinical therapeuticsC W Olanow, A L Finn
The Surgical Clinics of North America|August 1, 1980
Myasthenia gravisA S Wechsler, C W Olanow
Annals of Neurology|April 29, 2009
Withdrawal of figure 2 from McNaught and Olanow's article, "Proteasome inhibitor-induced model of Parkinson's disease" (Ann Neurol 2006;60:243-247)K S McNaught, C W Olanow
Archives of Neurology|October 1, 1991
Early therapy for Parkinson's diseaseR A Hauser, C W Olanow
Biochimica Et Biophysica Acta|March 17, 1999
Apoptosis in neurodegenerative diseases: the role of mitochondriaW G Tatton, C W Olanow
Annals of Neurology|April 13, 2000
Preventing levodopa-induced dyskinesiasC W Olanow, J A Obeso
Neurology|January 9, 2001
Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitorsC W Olanow, J A Obeso
Advances in Neurology|September 14, 2001
Surgical therapies for Parkinson's disease. A physician's perspectiveC W Olanow, M F Brin
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1981
Brain stem glioma in childhood: acute hemiplegic onsetS J Rothman, C W Olanow
Pageof 16